ZeeCRO has trial offices throughout North and South America, Europe and South Africa and provides a range of clinical development and pharmaceutical analysis services with a particular focus on oncology consulting.
The rebranding follows the sale of AAI Pharma’s development services unit to US private equity group Water Street Healthcare Partners (WSHP) in July this year.
WSHP continues to operate AAIPharma from its base in Wilmington, North Carolina under the AAIPharma Services brand name. The unit offers analytical chemistry, formulation development, clinical packaging, oral drug delivery and contract manufacturing services.